Advanced Search
ZHANG Chu, WANG Lin. Effects of Gefitinib Combined with Bruceolic Oil Emulsion on Human Lung Adenocarcinoma Cell Lines and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 965-969. DOI: 10.3971/j.issn.1000-8578.2015.10.003
Citation: ZHANG Chu, WANG Lin. Effects of Gefitinib Combined with Bruceolic Oil Emulsion on Human Lung Adenocarcinoma Cell Lines and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 965-969. DOI: 10.3971/j.issn.1000-8578.2015.10.003

Effects of Gefitinib Combined with Bruceolic Oil Emulsion on Human Lung Adenocarcinoma Cell Lines and Its Mechanism

More Information
  • Received Date: October 20, 2014
  • Revised Date: April 14, 2015
  • Objective To investigate the effects of gefitinib combined with bruceolic oil emulsion on the proliferation and apoptosis of human lung adenocarcinoma cell lines PC-9 and A549 and related mechanism. Methods PC-9 and A549 cell lines in logarithmic phase were divided into control group and experimental groups. MTT colorimetry, TUNEL assay and flow cytometry were used to detect the effects of gefitinib combined with bruceolic oil emulsion on cell proliferation, cell apoptosis and cell cycle in the experimental groups. Results Gefitinib and Bruceolic oil emulsion could inhibit the growth, proliferation and increase the apoptosis of PC-9 and A549 cell lines in a dose- and time-dependent manner. The growth inhibitory and apoptotic effects of the concomitant administration of gefitinib and bruceolic oil emulsion were higher than other groups. Conclusion Gefitinib and Bruceolic oil emulsion could significantly inhibit the proliferation and induce the apoptosis of PC-9 and A549 cell lines. The effects might be related to the retardation of drugs on cell cycle. Bruceolic oil emulsion has a synergy -increasing effect to gefitinib.
  • [1]
    Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
    [2]
    Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer (The IDEAL-1 Trial) [J]. J Clin Oncol, 2003, 21(12): 2237-46.
    [3]
    Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small cell lung cancer: a randomized trial[J]. JAMA, 2003, 290(16): 2149-58.
    [4]
    Fukuoka M, Wu YL, Thongprasert S, et al. Biomarker analyses and final overall survival results from a phase Ⅲ, randomized, openlabel, first-line study of gefitinib versus carboplatin/paclitaxed in clinically selected patients with advanced non-small-cell lung cancer in asia(IPASS)[J]. J Clin Oncol, 2011, 29(21): 2866-74.
    [5]
    Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR[J]. N Engl J Med, 2010, 362(25): 2381-8.
    [6]
    Mitsudomi T, Morita S, Yatabe Y, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor(WJTOG3405): an open label, randomised phase 3 trial[J]. Lancet Oncol, 2010, 11(12): 121-8.
    [7]
    Lin HY, Wu JM, Zhang WS. Progress on brucea javanica oil emulsion[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2006, 12(4): 65 -9. [林宏英, 吴建梅, 张文生. 鸦胆子油的研究进展[J]. 中国 实验方剂学杂志, 2006, 12(4): 65-9.]
    [8]
    Shan SS, Shu QJ. Study on the synergistic effect of aqueous extract taxus chinensis combining erlotinib on human lung carcinoma A549 cells in COX-2, MMP-2 expression[J]. Xinjiang Yi Ke Da Xue Xue Bao, 2013, 36(6): 789-92. [单双双, 舒琦瑾. 南方红豆 杉水提物协同厄洛替尼对人肺癌A549细胞COX-2、MMP-2表 达的影响[J]. 新疆医科大学学报, 2013, 36(6): 789-92.]
    [9]
    Zhang AQ, Sun Y, Gao FY. Reversing effect of β-elemene on human lung adenocarcinoma cell line PC9 with gefitinibresistant[ J] Zhongguo Zhong Liu, 2013, 22(2): 126-9. [张爱琴, 孙燕, 郜飞宇. β-榄香烯体外逆转人肺腺癌细胞PC9耐吉非替尼 的研究[J]. 中国肿瘤, 2013, 22(2): 126-9.]
    [10]
    Lin SQ, Wang SY, Song HS. Clinical analysis of 80 cases of lung cancer in elderly[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2002, 21 (5): 378. [蔺素琴, 王绍英, 宋慧胜. 老年人肺癌80例临床分析[J]. 中华老年医学杂志, 2002, 21(5): 378.]
    [11]
    Luo Y, Hao XZ, Zhang XR. The feasibility of chemotherapy in the elderly with advanced non-small cell lung cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2002, 29(3): 238-40. [罗扬, 郝学志, 张湘茹. 老年晚期非小细胞肺癌的化疗可行性[J]. 肿瘤防治研究, 2002, 29 (3): 238-40.]
    [12]
    Zhao Q, Li Y, Wang LL, et al. Effects of Shenqi Fuzheng injection on immune function in gastric carcinoma patients in Postoperational and chemotherapeutic period[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2001, 21(6): 424-6. [赵群, 李勇, 王力利, 等. 参 芪扶正注射液对胃癌患者手术及化疗时免疫功能的影响[J]. 中 国中西医结合杂志, 2001, 21(6): 424-6.]
    [13]
    Wang P. Efficacy of chemotherapy, radiotherapy with javanica oil emulsion on advanced gastric cancer[J]. Shi Yong Zhong Liu Za Zhi, 2004, 19(1): 78-9. [王佩. 化疗、放疗加鸦胆子油乳注射液 治疗晚期胃癌疗效观察[J]. 实用肿瘤杂志, 2004, 19(1): 78-9.]
    [14]
    Chen HL, Wang WP, Lan YP, et al. Clinical observation on treatment of non-small cell lung cancer with GP regimen and brucea fruitwater in oil emulsion[J]. Shi Yong Zhong Liu Za Zhi, 20 10, 25(5): 584-6. [陈海浪, 汪卫平, 兰永平, 等. 鸦胆子油乳联 合GP方案治疗晚期非小细胞肺癌临床疗效观察[J].实用肿瘤 杂志, 2010, 25(5): 584-6.]
    [15]
    Yao YW, Hu MW, Wang HQ. Observation on curative effect of Java Brucea Fruit Fat Emulsions Injection plus DP schema in treatment of patients with middle or advanced non-small cell lung cancer[J]. Shi Yong Zhong Liu Za Zhi, 2010, 25(1): 74-6. [姚扬 伟, 胡梦伟, 王海琴. 鸦胆子油乳注射液联合DP方案化疗治疗 中晚期非小细胞肺癌疗效观察[J]. 实用肿瘤杂志, 2010, 25(1): 74 -6.]
    [16]
    Yang J, Zhao LT, Li F, et al. Inhibitory effect of Brucea javanica oil self-microemulsion preparation on proliferation of human lung cancer cell line A549[J]. Di Er Jun Yi Da Xue Xue Bao, 2012, 33 (8): 928, 封3. [杨洁, 赵林涛, 李凡, 等. 鸦胆子油自微乳剂对 肺癌A549细胞增殖的抑制作用[J]. 第二军医大学学报, 2012, 33 (8): 928, cover3.]
    [17]
    Tang XL, Tang M. Progress on brucea javanica oil emulsion in cancer therapy[J]. Shi Jie Zhong Xi Yi Jie He Za Zhi, 2013, 8(4): 43 0-2. [唐晓玲, 唐敏. 鸦胆子油乳剂在肿瘤治疗中的应用研究 进展[J] 世界中西医结合杂志, 2013, 8(4): 430-2.]
    [18]
    Zhang XJ, Wang XL, Zhao F, et al. Inhibitory effect of Brucea javanica oil emulsion on proliferation of NCI-H460 cells and underlying mechanism[J]. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi, 2011(5): 519-23. [张晓娇, 王雪莲, 赵峰, 等. 鸦胆子 油乳抑制肺癌NCI-H460细胞的增殖及其机制[J]. 中国肿瘤生 物治疗杂志, 2011, 18(5): 519-23.]
    [19]
    Jiang B, Xu DH, Xu X, et al. Effects of javanica oil emulsion on apoptosis and vascular endothelial growth factor secretion of lung cancer cell line A549[J]. Zhongguo Yao Xue Za Zhi, 2009, 56 (18): 1387-91. [江波, 许东航, 徐翔, 等. 鸦胆子油乳对肺癌 A549细胞凋亡及血管内皮生长因子分泌的影响[J]. 中国药学 杂志, 2009, 56(18): 1387-91.]
  • Related Articles

    [1]SONG Peng, LONG Tong, LIANG Peiyu, OU Shanji. Effects of Long Non-coding RNA-MALAT1 on Proliferation and Apoptosis of Prostate Cancer Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(5): 411-416. DOI: 10.3971/j.issn.1000-8578.2019.18.1198
    [2]ZENG Qin, LIU Xun, CHEN Ming, YANG Zhihui. Effects of RNAi Silencing GTPBP4 Gene on Proliferation and Apoptosis of Colon Cancer RKO Cells[J]. Cancer Research on Prevention and Treatment, 2017, 44(1): 23-27. DOI: 10.3971/j.issn.1000-8578.2017.01.005
    [3]BIAN Jin, WANG Lin, XUN Chen, HUANG Wei, QIN Shukui. Sequence-dependent Effects and Mechanism of Pemetrexed and Gefitinib on Human Lung Adenocarcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1266-1270. DOI: 10.3971/j.issn.1000-8578.2014.12.002
    [4]YIN Baohui, JIA Xiuhong, LI Jianchang. Effects of RNA Interfere Targeting HOXA7 on Proliferation and Apoptosis of U937 Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 573-577. DOI: 10.3971/j.issn.1000-8578.2014.06.014
    [5]Zeng Yongqiu, Cao Yang, Mei Zhiqiang, Liu Lan, Shui Qinglin. Effects of SEPT9 Gene Silencing on Cell Proliferation and Apoptosis of HepG2 Hepatoma Cells[J]. Cancer Research on Prevention and Treatment, 2013, 40(03): 236-239. DOI: 10.3971/j.issn.1000-8578.2013.03.004
    [6]Chen Yan, Zhou Yongchun, Jin Congguo, Wu Zhiping, Liu Xin, Chen Xiaoqun, Li Jia, Wang Xicai. Inhibition of Lentivirus-mediated ITGB4 shRNA on H460SM Cell Proliferation[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1070-1075. DOI: 10.3971/j.issn.1000-8578.2012.09.007
    [7]Zhou Ruijuan, Chen Hongfeng, Ye Meina, Liao Mingjuan. Effects of Formononetin on Proliferation and Cell Cycle of Different Subtypes of Breast Cancer Cell Lines[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1051-1055. DOI: 10.3971/j.issn.1000-8578.2012.09.003
    [8]WANG Geng, HUANG Tao, XUE Jia-peng, WANG Ming-hua, HUI Zhen. Genistein Plays Antitumor Role through Cell Cycle and Apotosis Pathways in Human Breast Cancer Cell Line MCF-7/ADM in vitro[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 886-890. DOI: 10.3971/j.issn.1000-8578.2011.08.009
    [9]FENG Li-ying, QIN Yu-cai, MA Li, YIN Xi, SUN Ze-ming, TIAN Hui. Relationship between Expression of Trefoil Factor Family and Gastric Epithelial Cell Proliferation and Apoptosis in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(01): 63-65. DOI: 10.3971/j.issn.1000-8578.2010.01.017
    [10]Leng Jun, . The changes of cell cycle during the mucoepidermoid carcinoma cell apoptosis by Doxorubicin[J]. Cancer Research on Prevention and Treatment, 1998, 25(2): 92-94.

Catalog

    Article views (1918) PDF downloads (458) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return